Literatura académica sobre el tema "Pharmacoepigenetic"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Pharmacoepigenetic".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Pharmacoepigenetic"
Cacabelos, Ramón. "The PharmacoEpiGenetic Connection". Current Pharmacogenomics and Personalized Medicine 17, n.º 2 (28 de octubre de 2020): 72–75. http://dx.doi.org/10.2174/187569211702200921093217.
Texto completoKaraglani, Makrina, Georgia Ragia, Maria Panagopoulou, Ioanna Balgkouranidou, Evangelia Nena, George Kolios, Nikolaos Papanas, Vangelis Manolopoulos y Ekaterini Chatzaki. "Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment". Experimental and Clinical Endocrinology & Diabetes 127, n.º 04 (2 de febrero de 2018): 226–33. http://dx.doi.org/10.1055/s-0043-121265.
Texto completoYahaya, M. A. F., S. Z. I. Zolkiffly, M. A. M. Moklas, H. Abdul Hamid, J. Stanslas, M. Zainol y M. Z. Mehat. "Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer’s Disease". Journal of Immunology Research 2020 (10 de marzo de 2020): 1–7. http://dx.doi.org/10.1155/2020/9469210.
Texto completoSun, Yan y Robert Davis. "Rapid Collection of Biospecimens by Automated Identification of Patients Eligible for Pharmacoepigenetic Studies". Journal of Personalized Medicine 3, n.º 4 (26 de septiembre de 2013): 263–74. http://dx.doi.org/10.3390/jpm3040263.
Texto completoIngelman-Sundberg, Magnus, Sarah C. Sim, Alvin Gomez y Cristina Rodriguez-Antona. "Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects". Pharmacology & Therapeutics 116, n.º 3 (diciembre de 2007): 496–526. http://dx.doi.org/10.1016/j.pharmthera.2007.09.004.
Texto completoGomez, Alvin y Magnus Ingelman-Sundberg. "Pharmacoepigenetic aspects of gene polymorphism on drug therapies: effects of DNA methylation on drug response". Expert Review of Clinical Pharmacology 2, n.º 1 (enero de 2009): 55–65. http://dx.doi.org/10.1586/17512433.2.1.55.
Texto completoKhatami, Fatemeh, Mohammad R. Mohajeri-Tehrani y Seyed M. Tavangar. "The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects". Endocrine, Metabolic & Immune Disorders - Drug Targets 19, n.º 6 (3 de septiembre de 2019): 719–31. http://dx.doi.org/10.2174/1871530319666190228102212.
Texto completoCacabelos, Ramón, Juan Carril, Natalia Cacabelos, Aleksey Kazantsev, Alex Vostrov, Lola Corzo, Pablo Cacabelos y Dmitry Goldgaber. "Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics". International Journal of Molecular Sciences 20, n.º 5 (12 de marzo de 2019): 1249. http://dx.doi.org/10.3390/ijms20051249.
Texto completoLucafò, Marianna, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Alessia Di Silvestre, Chiara Pegolo et al. "miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway". Cancer Chemotherapy and Pharmacology 86, n.º 3 (10 de agosto de 2020): 361–74. http://dx.doi.org/10.1007/s00280-020-04122-z.
Texto completoCacabelos, Ramon. "Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia". International Journal of Molecular Sciences 21, n.º 9 (26 de abril de 2020): 3059. http://dx.doi.org/10.3390/ijms21093059.
Texto completoTesis sobre el tema "Pharmacoepigenetic"
Chu, Shih-Kai y 朱是鍇. "Interethnic DNA Methylation Difference and its Implications in Pharmacoepigenetics". Thesis, 2017. http://ndltd.ncl.edu.tw/handle/4t2br8.
Texto completo國立陽明大學
生物醫學資訊研究所
106
Using DNA methylation variants for evaluating the drug response and absorption, distribution, metabolism, and excretion (ADME) represents a crucial application in pharmacoepigenetics. However, the influence of the interethnic DNA methylation difference on the application in pharmacoepigenetics has not been studied systematically. In this dissertation, we analyzed the whole DNA methylome and RNA transcriptome data of primary tumor tissues of four cancer types (breast, colon, head and neck, and uterine corpus) from The Cancer Genome Atlas and lymphoblastoid cell lines from the International HapMap Project for African and European ancestry populations. The methylation data were generated by the Infinium HumanMethylation450 BeadChip and the gene expression data by RNA sequencing experiments. After data quality control, regression analyses with batch effect and covariate adjustments identified 307–20,287 ethnicity-associated CpG sites (E-CpGs) in the five datasets. E-CpG sites exhibited similar methylation patterns in the two studied populations; however, the patterns differed between tumor tissues and lymphoblastoid cell lines. E-CpG sites showed tumor-specific patterns of methylation and gene regulation. In addition, we observed that 264 E-CpG sites were associated with the drug response and ADME. For example, cg16919093 on BRCA1 and cg1055436 on FOXL2 were associated with the drug response to breast cancer chemotherapy; cg23283614 on DHRS7 and cg01878807 on DHRS4 were associated Phase I metabolism. We also identified E-CpG sites that triggered gene expression and influenced drug ADME. For example, the interethnic methylation difference for cg27560818 on SLC7A5 partially explained the poorer response to tamoxifen therapy in breast cancer patients with African ancestry than that in breast cancer patients with European ancestry. We also found that a small number of CpG sites exerted both ethnicity and methylation age effects on the drug response. In conclusion, we provide evidence about the influence of interethnic differences in DNA methylation on differential gene regulation and pharmacoepigenetics by tissue types. Ethnicity and tissue types should be carefully accounted for in future clinical practices and pharmacoepigenetics research.
Libros sobre el tema "Pharmacoepigenetic"
Pharmacoepigenetics. Elsevier, 2019. http://dx.doi.org/10.1016/c2017-0-00603-1.
Texto completoCacabelos, Ramón. Pharmacoepigenetics. Elsevier Science & Technology, 2019.
Buscar texto completoCacabelos, Ramón. Pharmacoepigenetics. Elsevier Science & Technology Books, 2019.
Buscar texto completoCacabelos, Ramón. Pharmacoepigenetics. Elsevier Science & Technology Books, 2024.
Buscar texto completoImani, Saber, Matteo Becatti y Md Asaduzzaman Khan, eds. Molecular Targeted Therapy in Oncology: Lessons from Pharmacogenetics and Pharmacoepigenetics. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-855-6.
Texto completoCapítulos de libros sobre el tema "Pharmacoepigenetic"
Zeitoun, R., E. Abou Diwan, R. Nasr y N. K. Zgheib. "Pharmacoepigenetic Considerations for the Treatment of Breast Cancer". En Pharmacoepigenetics, 531–39. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00015-2.
Texto completoCacabelos, Ramón, Juan C. Carril, Ana Sanmartín y Pablo Cacabelos. "Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics". En Pharmacoepigenetics, 191–424. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00006-1.
Texto completoFlanagan, James y Arturas Petronis. "Pharmacoepigenetics". En Drugs and the Pharmaceutical Sciences, 461–91. CRC Press, 2005. http://dx.doi.org/10.1201/9780849359507.ch20.
Texto completoCacabelos, Ramón, Iván Tellado y Pablo Cacabelos. "The Epigenetic Machinery in the Life Cycle and Pharmacoepigenetics". En Pharmacoepigenetics, 1–100. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00001-2.
Texto completoMajchrzak-Celińska, Aleksandra y Wanda Baer-Dubowska. "Pharmacoepigenetics: Basic Principles for Personalized Medicine". En Pharmacoepigenetics, 101–12. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00002-4.
Texto completoTeijido, Oscar. "Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport". En Pharmacoepigenetics, 113–28. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00003-6.
Texto completoLi, Dongying, William H. Tolleson, Dianke Yu, Si Chen, Lei Guo, Wenming Xiao, Weida Tong y Baitang Ning. "MicroRNA-Dependent Gene Regulation of the Human Cytochrome P450". En Pharmacoepigenetics, 129–38. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00004-8.
Texto completoCacabelos, Ramón. "Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis". En Pharmacoepigenetics, 139–89. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00005-x.
Texto completoDaifuku, Richard. "Pharmacoepigenetics of Novel Nucleoside DNA Methyltransferase Inhibitors". En Pharmacoepigenetics, 425–35. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00007-3.
Texto completoVilwanathan, Ravikumar, Anusha Chidambaram y Ramesh Kumar Chidambaram. "Pharmacoepigenetics: Novel Mechanistic Insights in Drug Discovery and Development Targeting Chromatin-Modifying Enzymes". En Pharmacoepigenetics, 437–45. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-813939-4.00008-5.
Texto completoActas de conferencias sobre el tema "Pharmacoepigenetic"
Lopez-Lopez, Elixabet, Idoia Martin-Guerrero, Javier Ballesteros, Javier Uriz, Nagore Garcia de Andoin, M. Angeles Piñan, Pura Garcia-Miguel, Aurora Navajas y Africa Garcia-Orad. "Abstract B31: Pharmacogenetics and pharmacoepigenetics of childhood acute lymphoblastic leukemia". En Abstracts: AACR International Conference on Translational Cancer Medicine--; Mar 21–24, 2010; Amsterdam, The Netherlands. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1078-0432.tcme10-b31.
Texto completo